A new approach for bolstering the ability of T cells to fight cancer
A collaborative study has discovered a new immune checkpoint that may be exploited for cancer therapy. The study shows that by inhibiting the protein tyrosine phosphatase PTP1B in T cells, the body’s immune response to cancer can be mobilized, helping to repress tumor growth.
Materials provided by Monash University. Note: Content may be edited for style and length.
Source link aaaaa